Hyperargininemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-12-09
EMA Authorised: Loargys (Pegzilarginase) — Immedica Pharma AB
The EMA has authorized Loargys (pegzilarginase) by Immedica Pharma AB for hyperargininemia, with orphan medicine designation indicating a ra…